Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation

Experimental Hematology

Volumn 28, Issue 5, 2000, Pages 519-526

  Teofili, Luciana ^a   Morosetti, Roberta ^a   Martini, Maurizio ^a   Urbano, Raffaella ^a   Putzulu, Rossana ^a   Rutella, Sergio ^a   Pierelli, Luca ^a   Leone, Giuseppe ^a   Larocca, Luigi Maria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Acute promyelocytic leukemia; All trans retinoic acid syndrome; Cyclin dependent kinase inhibitors; Hematopoietic differentiation

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P21; PROTEIN P27; RETINOIC ACID; RNA;

ACUTE LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD34; BONE MARROW CELLS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; KINETICS; LEUKEMIA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 0034104765     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00139-9     Document Type: Article

References (38)

1. Hirama T., Koeffler H.P. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood. 86:1995;841.
2. Hall M., Bates S., Peters G. Evidence for different modes of action of cyclin-dependent kinase inhibitors. p15 and p16 bind to kinases, p21 and p27 bind to cyclins Oncogene. 11:1995;1581.
3. Reynisdottir I., Polyak C., Iavarone A., Massagué J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β Genes Dev. 9:1995;1831.
4. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:1997;492.
5. Steinman R.A., Huang J., Yaroslavskiy B., Goff J.P., Ball E.D., Nguyen A. regulation of p21(WAF1) expression during normal myeloid differentiation. Blood. 91:1998;4531.
6. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., El-Houseini M.E. Induction of p21(WAF1/CIP1) during differentiation. Oncogene. 9:1994;3389.
7. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21WAF1/CIP1 expression in the absence of p53. Oncogene. 9:1994;3397.
8. Zhang W., Grasso L., McClain C.D.et al. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55:1995;668.
9. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142.
10. INK4B in normal hematopoiesis. Exp Hematol. 26:1998;1133.
11. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 12:1998;845.
12. INK4B1. Cancer Res. 56:1996;722.
13. INK4A characterize the major types of hematological malignancies. Cancer Res. 57:1997;837.
14. INK4B gene in myelodysplastic syndromes. Blood. 90:1997;1403.
15. INK4B methylation in acute myeloid leukemia. Cancer Res. 59:1997;436.
16. INK4B CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood. 94:1999;2445.
17. INK4B gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood. 91:1998;2985.
18. INK4B in primary leukemic blasts and its modulation by quercetin. Exp Hematol. 24:1996;1122. (abstr).
19. Grignani F., Fagioli M., Alcalay M.et al. Acute promyelocytic leukemia. from genetics to treatment Blood. 83:1994;10.
20. Bennet J.M., Catowsky D., Daniel M.T.et al. Proposal for the classification of the acute leukemias. Br J Haematol. 33:1976;451.
21. Diverio D., Riccioni R., Mandelli F., Lo Coco F. The PML/RARa fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia. Hematologica. 80:1995;155.
22. Frankel S.R., Eardley A., Lauwers G., Weiss M., Warrel R. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med. 117:1992;292.
23. + haematopoietic progenitors. Br J Haematol. 102:1998;1139.
24. De Stefano V., Teofili L., Sica S.et al. Effect of all trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood. 86:1995;3535.
25. Morosetti R., Park D.J., Chumakov A.M.et al. A novel myeloid transcription factor, C/EBPε, is up-regulated during granulocytic but not monocytic differentiation. Blood. 90:1997;2591.
26. Yaroslavskji B., Watkins S., Donnenberg A.D., Patton T.J., Steinman R.A. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood. 93:1999;2907.
27. Kip1 cycling dependent kinases inhibitors during human hematopoiesis. Blood. 93:1999;4167.
28. Kuter D.J., Gminski D.M., Rosemberg R.D. Transforming growth factor-β inhibits megakaryocyte growth and endomitosis. Blood. 79:1992;619.
29. Sakamaki S., Hirayama Y., Matsunaga T.et al. Transforming growth facto-β1 (TGF-β1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-β receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-β itself with high specificity. Blood. 94:1999;1961.
30. WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem. 271:1996;31723.
31. Visani G., Ottaviani E., Zauli G.et al. All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines. Eur J Hematol. 63:1999;149.
32. Kinjo K., Kizaki M., Takayama N.et al. Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukemia during all-trans retinoic acid treatment. Br J Haematol. 105:1999;382.
33. Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 77:1991;1080.
34. De Bottom S., Dombret H., Sanz S.et al. Incidence, clinical feature and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood. 92:1998;2712.
35. Larson R., Brown D., Sklar L. Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB4 by utilization of LFA-1 and ICAM-2. Blood. 90:1997;2747.
36. Grande A., Manfredini R., Tagliafico E.et al. All trans retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp Hematol. 23:1995;117.
37. Dubois C., Schlageter M.H., De Gentile A.et al. Modulation of IL-8 and IL-1b and G-CSF secretion by all trans retinoic acid in acute promyelocytic leukemia. Leukemia. 8:1994;1750.
38. Morosetti R., Martini M., Teofili L.et al. ATRA up-regulates the expression of C/EBPε in blasts from APL patients in a secondary AML, but not in blasts from APL patients with ATRA syndrome. Cancer Res. 40:1999;4069. (abstr).